Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT02337478 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped The study was stopped early due to futility.

Conditions

Recurrent Adult Acute Myeloid Leukemia

Interventions

DRUG: Vincristine Sulfate Liposome
OTHER: Laboratory Biomarker Analysis

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]
[object Object]